"Soluble ferric pyrophosphate significantly reduces the need for erythropoiesis-stimulating agents and intravenous iron agents without an intravenous iron source. It appears very safe," said Dr. Gupta.
There is still more work to be done, said Ziad Massy, MD, professor of nephrology at Ambroise Paré Hospital in Paris, France, who attended the session.
"Depending on how much iron you deliver and how fast you deliver it, the concern is always that you can increase oxidative stress. We need more data on the safety of this delivery method, especially for oxidative stress markers," Dr. Massy told Medscape Medical News. However, he acknowledged, "Dr. Gupta said he is going to do it."